• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年112个国家肝脏疾病相关死亡率的全球、区域和国家趋势及到2050年的预测:对世界卫生组织死亡率数据库的综合分析

Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database.

作者信息

Hahn Jong Woo, Woo Selin, Park Jaeyu, Lee Hyeri, Kim Hyeon Jin, Ko Jae Sung, Moon Jin Soo, Rahmati Masoud, Smith Lee, Kang Jiseung, Pizzol Damiano, Tully Mark A, Dragioti Elena, Sánchez Guillermo F López, Lee Kwanjoo, Ha Yeonjung, Lee Jinseok, Lee Hayeon, Rhee Sang Youl, Son Yejun, Kim Soeun, Yon Dong Keon

机构信息

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.

Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

J Korean Med Sci. 2024 Dec 2;39(46):e292. doi: 10.3346/jkms.2024.39.e292.

DOI:10.3346/jkms.2024.39.e292
PMID:39623966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11611658/
Abstract

BACKGROUND

Liver disease causes over two million deaths annually worldwide, comprising approximately 4% of all global fatalities. We aimed to analyze liver disease-related mortality trends from 1990 to 2021 using the World Health Organization (WHO) Mortality Database and forecast global liver disease-related mortality rates up to 2050.

METHODS

This study examined age-standardized liver disease-related death rates from 1990 to 2021, employing data from the WHO Mortality Database across 112 countries across five continents. The rates over time were calculated using a locally weighted scatter plot smoother curve, with weights assigned based on the population of each country. Furthermore, this study projected liver disease-related mortality rates up to 2050 using a Bayesian age-period-cohort (BAPC) model. Additionally, a decomposition analysis was conducted to discern influencing factors such as population growth, aging, and epidemiological changes.

RESULTS

The estimated global age-standardized liver disease-related mortality rates surged significantly from 1990 to 2021 across 112 countries, rising from 103.4 deaths per 1,000,000 people (95% confidence interval [CI], 88.16, 118.74) in 1990 to 173.0 deaths per 1,000,000 people (95% CI, 155.15, 190.95) in 2021. This upward trend was particularly pronounced in low- and middle-income countries, in Africa, and in populations aged 65 years and older. Moreover, age-standardized liver disease-related mortality rates were correlated with a lower Human Development Index ( < 0.001) and sociodemographic index ( = 0.001). According to the BAPC model, the projected trend indicated a sustained and substantial decline in liver disease-related mortality rates, with an estimated decrease from 185.08 deaths per 1,000,000 people (95% CI, 179.79, 190.63) in 2021 to 156.29 (112.32, 214.77) in 2050. From 1990 to 2021, age-standardized liver disease-related deaths surged primarily due to epidemiological changes, whereas from 1990 to 2050, the impact of population aging and growth became the primary contributing factors to the overall increase.

CONCLUSION

Global age-standardized liver disease-related mortality has increased significantly and continues to emerge as a crucial global public health issue. Further investigation into liver disease-related mortality rates in Africa is needed, and updating policies is necessary to effectively manage the global burden of liver disease.

摘要

背景

肝病每年在全球导致超过200万人死亡,约占全球总死亡人数的4%。我们旨在利用世界卫生组织(WHO)死亡率数据库分析1990年至2021年期间与肝病相关的死亡率趋势,并预测到2050年全球与肝病相关的死亡率。

方法

本研究使用来自五大洲112个国家的WHO死亡率数据库数据,考察了1990年至2021年年龄标准化的与肝病相关的死亡率。随时间变化的死亡率使用局部加权散点图平滑曲线计算,权重根据每个国家的人口分配。此外,本研究使用贝叶斯年龄-时期-队列(BAPC)模型预测了到2050年与肝病相关的死亡率。另外,进行了分解分析以识别诸如人口增长、老龄化和流行病学变化等影响因素。

结果

1990年至2021年期间,112个国家的估计全球年龄标准化与肝病相关的死亡率显著上升,从1990年的每100万人中有103.4例死亡(95%置信区间[CI],88.16,118.74)升至2021年的每100万人中有173.0例死亡(95%CI,155.15,190.95)。这种上升趋势在低收入和中等收入国家、非洲以及65岁及以上人群中尤为明显。此外,年龄标准化与肝病相关的死亡率与较低的人类发展指数(<0.001)和社会人口指数(=0.001)相关。根据BAPC模型,预测趋势表明与肝病相关的死亡率将持续大幅下降,预计从2021年的每100万人中有185.08例死亡(95%CI,179.79,190.63)降至2050年的156.29例(112.32,214.77)。从1990年至2021年,年龄标准化与肝病相关的死亡人数激增主要归因于流行病学变化,而从1990年至2050年,人口老龄化和增长的影响成为总体上升的主要促成因素。

结论

全球年龄标准化与肝病相关的死亡率显著上升,并且仍然是一个关键的全球公共卫生问题。需要进一步调查非洲与肝病相关的死亡率,并且有必要更新政策以有效管理全球肝病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/0baa27ed1462/jkms-39-e292-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/5cd8c86a3697/jkms-39-e292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/1b70bd38c5a3/jkms-39-e292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/9d7a9ac3c613/jkms-39-e292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/5766eff2413a/jkms-39-e292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/ae7ad83ac1ae/jkms-39-e292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/47777cf8cc8f/jkms-39-e292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/0baa27ed1462/jkms-39-e292-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/5cd8c86a3697/jkms-39-e292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/1b70bd38c5a3/jkms-39-e292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/9d7a9ac3c613/jkms-39-e292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/5766eff2413a/jkms-39-e292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/ae7ad83ac1ae/jkms-39-e292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/47777cf8cc8f/jkms-39-e292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a4/11611658/0baa27ed1462/jkms-39-e292-g007.jpg

相似文献

1
Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database.1990年至2021年112个国家肝脏疾病相关死亡率的全球、区域和国家趋势及到2050年的预测:对世界卫生组织死亡率数据库的综合分析
J Korean Med Sci. 2024 Dec 2;39(46):e292. doi: 10.3346/jkms.2024.39.e292.
2
Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study.1990年至2021年59个高收入和中高收入国家跌倒死亡率的时间趋势和模式,以及到2040年的预测:一项全球时间序列分析和建模研究
Lancet Healthy Longev. 2025 Jan;6(1):100672. doi: 10.1016/j.lanhl.2024.100672. Epub 2025 Jan 20.
3
Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study.1990年至2021年73个国家药物使用障碍死亡率的全球、区域和国家趋势以及到2040年的预测:一项全球时间序列分析与建模研究
EClinicalMedicine. 2024 Dec 17;79:102985. doi: 10.1016/j.eclinm.2024.102985. eCollection 2025 Jan.
4
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
5
Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data.基于 GBD、CI5plus 和世卫组织数据预测 2040 年肝癌的流行趋势和负担。
Sci Rep. 2024 Nov 15;14(1):28131. doi: 10.1038/s41598-024-77658-2.
6
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区的全球生育率,1950-2021 年,预测至 2100 年:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):2057-2099. doi: 10.1016/S0140-6736(24)00550-6. Epub 2024 Mar 20.
7
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
8
Global, regional and national temporal trends in Parkinson's disease incidence, disability-adjusted life year rates in middle-aged and older adults: a cross-national inequality analysis and Bayesian age-period-cohort analysis based on the global burden of disease 2021.全球、区域和国家帕金森病发病率及时年趋势、中老年人群伤残调整生命年率:基于2021年全球疾病负担的跨国不平等分析和贝叶斯年龄-时期-队列分析
Neurol Sci. 2025 Apr;46(4):1647-1660. doi: 10.1007/s10072-024-07941-7. Epub 2024 Dec 14.
9
Global burden of gallbladder and biliary diseases (1990-2021) with healthcare workforce analysis and projections to 2035.1990年至2021年胆囊及胆道疾病的全球负担,附医疗保健人力分析及到2035年的预测
BMC Gastroenterol. 2025 Apr 12;25(1):249. doi: 10.1186/s12876-025-03842-x.
10
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.

引用本文的文献

1
Correlation of Income Instability With 12 Non-Communicable Disease Risks in Korea: A Prospective Cohort Study.韩国收入不稳定与12种非传染性疾病风险的相关性:一项前瞻性队列研究。
J Korean Med Sci. 2025 Aug 4;40(30):e180. doi: 10.3346/jkms.2025.40.e180.
2
Global, Regional, and National Burden of Pharyngeal Cancer and Projections to 2050 in 185 Countries: A Population-Based Systematic Analysis of GLOBOCAN 2022.185个国家咽癌的全球、区域和国家负担以及到2050年的预测:基于全球疾病负担研究(GLOBOCAN)2022的人群系统分析
J Korean Med Sci. 2025 Aug 4;40(30):e177. doi: 10.3346/jkms.2025.40.e177.
3
Deciphering the role of in liver diseases: Mechanisms, clinical relevance, and emerging therapeutic opportunities.

本文引用的文献

1
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis.韩国乙型肝炎病毒感染的流行病学:15 年分析。
J Korean Med Sci. 2024 Jan 29;39(4):e22. doi: 10.3346/jkms.2024.39.e22.
2
Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada.使用直接作用抗病毒药物治疗丙型肝炎病毒对降低与肝外表现相关的死亡率的影响:加拿大不列颠哥伦比亚省一项基于人群的大型研究。
Lancet Reg Health Am. 2023 Dec 29;29:100658. doi: 10.1016/j.lana.2023.100658. eCollection 2024 Jan.
3
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa.
解读[具体物质或因素]在肝脏疾病中的作用:机制、临床相关性及新出现的治疗机会。 (注:原文中“of”后面缺少具体内容)
World J Hepatol. 2025 Jul 27;17(7):106795. doi: 10.4254/wjh.v17.i7.106795.
4
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
5
Global, Regional, and National Trends in Maternal Mortality Ratio Across 37 High Income Countries From 1990 to 2021, With Projections up to 2050: A Comprehensive Analysis From the WHO Mortality Database.1990年至2021年37个高收入国家孕产妇死亡率的全球、区域和国家趋势,以及到2050年的预测:来自世界卫生组织死亡率数据库的综合分析
J Korean Med Sci. 2025 Jun 2;40(21):e85. doi: 10.3346/jkms.2025.40.e85.
6
Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study.1990年至2021年73个国家药物使用障碍死亡率的全球、区域和国家趋势以及到2040年的预测:一项全球时间序列分析与建模研究
EClinicalMedicine. 2024 Dec 17;79:102985. doi: 10.1016/j.eclinm.2024.102985. eCollection 2025 Jan.
7
Racial Discrimination and Multiple Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses.种族歧视与多种健康结局:系统评价与荟萃分析的伞形综述
Med Princ Pract. 2025;34(2):138-151. doi: 10.1159/000542988. Epub 2024 Dec 5.
在有限资源下管理肝硬化:来自撒哈拉以南非洲的观点。
Lancet Gastroenterol Hepatol. 2024 Feb;9(2):170-184. doi: 10.1016/S2468-1253(23)00279-0.
4
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.从阴影到聚光灯下:探索年轻女性中与酒精相关的肝脏疾病和酒精使用障碍的日益加重的负担。
Am J Gastroenterol. 2024 May 1;119(5):893-909. doi: 10.14309/ajg.0000000000002642. Epub 2023 Dec 26.
5
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data.中国 2005-20 年的癌症负担的国家和省级趋势:基于国家死亡率监测数据的分析。
Lancet Public Health. 2023 Dec;8(12):e943-e955. doi: 10.1016/S2468-2667(23)00211-6.
6
Advances in the understanding and management of alcohol-related liver disease.酒精性肝病的认识和管理进展。
BMJ. 2023 Nov 20;383:e077090. doi: 10.1136/bmj-2023-077090.
7
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.全球肝细胞癌流行病学趋势:对筛查、预防和治疗的启示。
Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26.
8
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis.1970 - 2022年自身免疫性肝炎的全球发病率和患病率:一项系统评价和荟萃分析
EClinicalMedicine. 2023 Oct 17;65:102280. doi: 10.1016/j.eclinm.2023.102280. eCollection 2023 Nov.
9
Acute liver failure in low-income and middle-income countries.中低收入国家的急性肝衰竭。
Lancet Gastroenterol Hepatol. 2023 Nov;8(11):1035-1045. doi: 10.1016/S2468-1253(23)00142-5.
10
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis.老年人非酒精性脂肪性肝病的无声负担:全球疾病负担分析。
Aliment Pharmacol Ther. 2023 Nov;58(10):1062-1074. doi: 10.1111/apt.17714. Epub 2023 Sep 11.